BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10093435)

  • 1. [Mammographic screening fulfills the requirements of health control].
    Sandelin K
    Lakartidningen; 1999 Mar; 96(9):983-4. PubMed ID: 10093435
    [No Abstract]   [Full Text] [Related]  

  • 2. [Reduced mortality with mammographic screening. The natural course, too rough methods resulted in miscalculation on breast cancer].
    Rutqvist LE
    Lakartidningen; 1999 Mar; 96(10):1210-1. PubMed ID: 10193130
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of mammographic screening at the Mammary Center of Debrecen in 1999 and 2000].
    Simon E; Péter M; Benkó K; Horkay E; Erdélyi G; Péter M; Szúcs-Farkas Z; Tóth J; Kovács I; Fülöp B
    Orv Hetil; 2002 Apr; 143(14):721-3. PubMed ID: 11975392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The National Board of Health and Welfare on mammographic screening: mortality analysis requires completely different methods].
    Rehnqvist N; Rosén M; Karlberg I
    Lakartidningen; 1999 Mar; 96(9):1050-1. PubMed ID: 10093453
    [No Abstract]   [Full Text] [Related]  

  • 5. Breast cancer screening. Interpreting new data for clinical practice.
    Daly L
    Physician Assist; 1994 Oct; 18(10):47-51, 56, 61-6. PubMed ID: 10138304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [European recommendations for quality assurance in the setting of mammographic screening for breast cancer. Report of pathologists of the working group "Breast Cancer Screening" of the European Union].
    Ann Pathol; 1996 Nov; 16(5):315-33. PubMed ID: 9004719
    [No Abstract]   [Full Text] [Related]  

  • 7. [Assessment of the effect of mammographic screening can not be based on wrong data].
    Tabár L
    Lakartidningen; 1999 Apr; 96(14):1763-4. PubMed ID: 10222696
    [No Abstract]   [Full Text] [Related]  

  • 8. [The quality of mammography scrutinized. Ongoing control mass screenings for breast cancer is necessary].
    Andersson I; Rydén S; Karlberg I
    Lakartidningen; 1995 Aug; 92(35):3106-9. PubMed ID: 7658762
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening mammography in women 40 to 49 years of age.
    Lisby MD
    Am Fam Physician; 2004 Nov; 70(9):1750-2. PubMed ID: 15554494
    [No Abstract]   [Full Text] [Related]  

  • 10. Scientific uncertainty in clinical practice.
    Greiver M
    Can Fam Physician; 1998 Sep; 44():1773-5, 1785-7. PubMed ID: 9789654
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for breast cancer: what to do with the evidence.
    Harris R
    Am Fam Physician; 2007 Jun; 75(11):1623-4, 1626. PubMed ID: 17575651
    [No Abstract]   [Full Text] [Related]  

  • 12. Gøtzsche's quixotic antiscreening campaign: nonscientific and contrary to Cochrane principles.
    Dean PB
    J Am Coll Radiol; 2004 Jan; 1(1):3-7. PubMed ID: 17411510
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent controversies in mammography screening for breast cancer.
    McTiernan A
    Medscape Womens Health; 2002; 7(2):3. PubMed ID: 12142859
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening for breast cancer in women over the age of 70.
    Gifford D
    Med Health R I; 2001 Apr; 84(4):136-7. PubMed ID: 11347352
    [No Abstract]   [Full Text] [Related]  

  • 15. Service screening with mammography in Northern Sweden: effects on breast cancer mortality - an update.
    Jonsson H; Bordás P; Wallin H; Nyström L; Lenner P
    J Med Screen; 2007; 14(2):87-93. PubMed ID: 17626708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of service screening mammography on population mortality from breast carcinoma.
    Feig SA
    Cancer; 2002 Aug; 95(3):451-7. PubMed ID: 12209736
    [No Abstract]   [Full Text] [Related]  

  • 17. Ramifications of screening for breast cancer: 1 in 4 cancers detected by mammography are pseudocancers.
    Welch HG; Schwartz LM; Woloshin S
    BMJ; 2006 Mar; 332(7543):727. PubMed ID: 16565136
    [No Abstract]   [Full Text] [Related]  

  • 18. Canadian National Breast Screening Study.
    Courteau JP; Bouchard F
    CMAJ; 1993 Mar; 148(6):875; author reply 880-3. PubMed ID: 8448694
    [No Abstract]   [Full Text] [Related]  

  • 19. Mammographic screening only matters in the detectable preclinical period of breast cancer.
    Broeders MJ; Verbeek AL
    J Med Screen; 2005; 12(2):107; author reply 107. PubMed ID: 15949123
    [No Abstract]   [Full Text] [Related]  

  • 20. Ramifications of screening for breast cancer: consent for screening.
    Baum M
    BMJ; 2006 Mar; 332(7543):728. PubMed ID: 16565139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.